AVAC's Micheal Ighodaro reflects on the atmosphere at the National African-American MSM Leadership Conference.
Most women do not know that pre-exposure prophylaxis (PrEP) may be an HIV prevention option for them. Here's how advocates and providers are working to change that.
Some HIV journalists got a nasty surprise recently when they attempted to register for NMAC's National HIV PrEP Summit.
While the use of PrEP has increased since it was approved in 2012, its use in the communities where it is most needed remains low. What can we do to change this?
"If we can't even talk openly about HIV, how are we going to talk about medications to prevent HIV?" Áugustu writes.
Kenneth Mwehonge hears cries about the high price of HIV prevention options all the time, but hears little conversation about reducing these high costs and enabling access.
NHS England Fudges PrEP Access and Delays On-Demand Access to PrEP by Years; Blocks Doctors From Prescribing PrEP Now
"After almost a year of turmoil a new [NHS] press statement still fails to allow a single doctor to protect the health of their patients by prescribing PrEP," Simon Collins writes.
Project Inform and HIVE launch new pre-exposure prophylaxis (PrEP) videos for women in English and Spanish.
"Gilead is not following the accepted standard for community engagement in its new pre-exposure prophylaxis (PrEP) trial," write Anna Forbes and Marc-André LeBlanc, explaining that concern is inspired, in part, by controversies in earlier PrEP trials...
"We continue to follow the research regarding PrEP including new cases of HIV transmission, despite PrEP adherence," AVAC writes. "However, it is important not to overreact to these cases as well."